N-cyclohexyl-3-((2,3-dihydrobenzo[b][1,4]dioxine)-6-sulfonamido)-4-(8-oxo-1,5,6,8-tetrahydro-2H-1,5-methanopyrido[1,2-a][1,5]diazocin-3(4H)-yl)benzamide
$360.00
CAS No.: 688794-42-5
Catalog No.: 198451
Purity: 95%
MF: C32H36N4O6S
MW: 604.729
Storage: 2-8 degree Celsius
SMILES: O=C(NC1CCCCC1)C2=CC=C(N3CC(C4)C(N5CC4C3)=CC=CC5=O)C(NS(=O)(C6=CC=C7OCCOC7=C6)=O)=C2
Catalog No.: 198451
Purity: 95%
MF: C32H36N4O6S
MW: 604.729
Storage: 2-8 degree Celsius
SMILES: O=C(NC1CCCCC1)C2=CC=C(N3CC(C4)C(N5CC4C3)=CC=CC5=O)C(NS(=O)(C6=CC=C7OCCOC7=C6)=O)=C2
CAS No.:688794-42-5;N-cyclohexyl-3-((2,3-dihydrobenzo[b][1,4]dioxine)-6-sulfonamido)-4-(8-oxo-1,5,6,8-tetrahydro-2H-1,5-methanopyrido[1,2-a][1,5]diazocin-3(4H)-yl)benzamide;ChemShuttle distinguishes itself as a custom chemical synthesis company by providing highly complex and specialized compounds such as the N-cyclohexyl-3-((2,3-dihydrobenzo[b][1,4]dioxine)-6-sulfonamido)-4-(8-oxo-1,5,6,8-tetrahydro-2H-1,5-methanopyrido[1,2-a][1,5]diazocin-3(4H)-yl)benzamide (CAS No.:688794-42-5). This compound represents the pinnacle of our offerings in terms of chemical complexity and potential for advanced research applications. The molecule combines several distinct pharmacophores: a sulfonamido group attached to a dihydrobenzodioxine ring, a benzamide moiety, and a substituted diazocin core. Such a combination creates a versatile platform for exploring interactions with various biological targets. As a leading chemical distributor and custom synthesis provider, we recognize the need for such intricate building blocks in the development of novel pharmaceuticals and chemical tools. Our expertise in process chemistry allows us to produce this compound with high purity and consistency, supporting researchers in their drug discovery projects through our extensive library of compounds. The multiple points for chemical modification, including the benzamide, sulfonamido, and diazocin functionalities, offer researchers the flexibility to tailor this compound to their specific needs, making it an invaluable asset in the pursuit of innovative therapeutic solutions.
Reviews
Write Your Own Review